ADAMTS13 and obesity due to melanocortin 4 receptor deficiency: Given that obesity may influence ADAMTS13 activity, it is feasible; however, it remains unclear whether ADAMTS13 activity acts as a mediator between obesity and COVID-19 outcomes.